Design, synthesis, and SAR of antiproliferative activity of trioxatriangulene derivatives

Abstract

Trioxatriangulene (TOTA+) and its derivatives, which are primarily used as dyes in biological systems, have received considerable attention owing to their photophysical and electronic properties. Notably, their DNA-intercalating properties have been well established. Previous studies have identified TOTA+ derivatives, particularly ADOTA+ (R = –C3H7) and DAOTA+ (R = R′ = –C3H7), as potent antiproliferative agents in triple-negative breast cancer (MDA-MB-231) and colorectal cancer (HCT-116) cell lines. However, the potential to enhance antiproliferative activity through different side chains prompted further investigation. In addition, partially cyclized tetramethoxyphenyl acridinium ion (TMPA+ 8) and dimethoxy quinacridinium ion (DMQA+ 9) intermediates were assessed to elucidate the structure–activity relationship (SAR) of the triangulenium core for antiproliferative activity. In this study, 83 molecules with various side chains were synthesized, including planar, partially planar, and non-planar derivatives. Evaluation of their antiproliferative activity in MDA-MB-231 and HCT-116 cell lines revealed that compound 6l (R = –C4H9, R′ = –C2H4N(Me)2) was the most potent inhibitor, with IC50 values of 18 ± 3 nM and 32 ± 14 nM, respectively. A new one-pot method was developed to synthesize symmetrically and asymmetrically substituted DAOTA+ molecules, enabling the introduction of acid-labile functional groups, such as alcohols, ethers, and alkylamines, in moderate to good yields.

Graphical abstract: Design, synthesis, and SAR of antiproliferative activity of trioxatriangulene derivatives

Supplementary files

Article information

Article type
Research Article
Submitted
07 Nov 2024
Accepted
06 Mar 2025
First published
07 Mar 2025

RSC Med. Chem., 2025, Advance Article

Design, synthesis, and SAR of antiproliferative activity of trioxatriangulene derivatives

M. M. Naiya, I. A. Guan, M. Sullivan, C. Eurtivong, E. Leung, L. I. Pilkington and D. Barker, RSC Med. Chem., 2025, Advance Article , DOI: 10.1039/D4MD00867G

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements